What men who have sex with men think about the human papillomavirus vaccine
- 1School of Population Health, University of Melbourne, Victoria, Australia
- 2Melbourne Sexual Health Centre, Alfred Hospital and Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
- 3Melbourne Sexual Health Centre, Alfred Hospital, Melbourne, Victoria, Australia
- Clinical Associate Professor Marcus Y Chen, Melbourne Sexual Health Centre, 580 Swanston Street, Carlton, Victoria, Australia, 3053;
- Accepted 10 January 2009
- Published Online First 19 January 2009
This study aimed to ascertain the attitudes of men who have sex with men (MSM) to the human papillomavirus (HPV) vaccine and to determine the age at which MSM would be willing to ask for the HPV vaccine in relation to their age of sexual debut. Of 205 MSM attending the Melbourne Sexual Health Centre between December 2007 and January 2008, 200 (98%; median age 27 years) completed the study questionnaire. Only 30% were aware that there was a vaccine available for protection against infection with certain HPV types. When informed of the increased risk of anal cancer among MSM, 47% of MSM indicated that they would be willing to pay $A450 for the vaccine course. A total of 93% indicated that they would be willing to disclose that they were MSM to a health professional in order to obtain the vaccine for free, but not until a median age of 20 years: 2 years after the median age of sexual debut (18 years) and after a median of 15 sexual partners. If the HPV vaccine is targeted to MSM, the challenge will be for MSM to be vaccinated before they acquire HPV infection.
Competing interests: None.
Ethics approval: Ethics approval for the project was obtained from the Alfred Hospital Human Research Ethics Committee.
Contributors: All authors contributed to the design of the study, drafting of the questionnaire, and writing and editing of the manuscript. DS was responsible for recruitment and data collection. DS, MYC and CB analysed the data.